Structural basis of viral RBDs binding to cell receptors

NIH Pandemic-Era Grants

Pandemic Era Grants

2022

Document text

Principal Investigator: Philippe  Youkharibache
Organization: DIVISION OF BASIC SCIENCES - NCI
Fiscal Year: 2022
Award: $37,847
Funding agency: National Cancer Institute

A significant part of my recent research efforts is focused on studying      self-association determinants of molecular systems as revealed by their structural symmetries      at several levels: from proteins assemblies to their protein supersecondary structures      constituents (protodomains) [Youkharibache 2019]. We have shown in particular that many      important structural families of Polytopic Helical Membrane Proteins followed a common      Pseudo-Symmetric evolutionary process in their construction [Youkharibache, Tran, and Abrol      2020]. This is the case for G protein-coupled receptors (GPCRs), SLCs with an MFS fold such as      SLC2A1/GLUT1, a glucose transporter used as a receptor by HTLV, or SLC7A1/CAT1, an arginine      transporter and a receptor for mouse and bovine leukemia retroviruses. Our structural analyses      have been enabled by innovative software that we developed in collaboration with NCBI [Wang et      al. 2020], and a significant body of structural data has been obtained, that we are now      harnessing to study their interactions with protein ligands on cell surfaces. Vertebrate      retroviruses as different as the Human T-cell leukemia virus (HTLV) and the bovine leukemia      virus, the large family of simian/murine/feline leukemia viruses, and many members of the      non-infectious human endogenous retroviruses (HERV) that are constitutively present in the      human genome, use their receptor-binding domains (RBDs) in the virus envelope glycoprotein to      bind nutrient transporters of the SLC family as an initial step in cell entry. SLCs condition      cell metabolism and their expression is systematically altered during normal cell      differentiation and oncogenic processes. In collaboration with the IGMM (CNRS Montpellier,      France) and the start-up Metafora-biosystems (Paris, France), we aim to study RBDs that bind      SLCs that play a key role in oncogenic processes and immune response: notably the transporters      of glucose and amino acids including glutamine, serine, and arginine. Among the family of RBDs      that can commonly or distinctively bind glutamine and/or other neutral amino acid transporters      (SLC1A5/ASCT2 and SLC1A4/ASCT1, respectively) are the BaEV and HERV-W RBDs. Another family of      RBDs that distinctively bind glucose or arginine transporters - SLC2A1/GLUT1 and SLC7A1/CAT1 -      includes the HTLV and BLV RBDs, respectively. We aim to study structural interactions between      viral RBDs and SLCs and the role of SLCs in viral infections, oncogenesis, and immunological      responses. Elucidating RBD-SLC interactions will also help designing synthetic SLC modulators      either directly derived from RBDs or designed de novo. Recently, it was shown that SARS-CoV2      RBD binds to a receptor complex that includes ACE2, TMPRSS2, but also SLC6A19, a glutamine and      other neutral amino acids transporters that also belongs to the SLC superfamily. We have      performed initial structural analyses and developed structural analysis tools to enable      collaborative research, especially on cell surface proteins-RBD interactions [Youkharibache et      al. 2020]. The software and pipelines are being improved to support the aims of the      project.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ACE2><Amino Acid Channel><Amino Acid Transport Systems><Amino Acid Transporter><Amino Acids><Animals><Antigenic Determinants><Antiviral Agents><Antiviral Drugs><Antivirals><Arginine><Baboons><Binding><Binding Determinants><Biological Markers><Bovine Leukemia Virus><Bovine leukemia><CCL21><CCL21 gene><CKb9><COVID-19 virus><COVID19 virus><Cat Leukemia Virus><Cattle Leukemia Virus><Cell Body><Cell Differentiation><Cell Differentiation process><Cell Surface Proteins><Cell Surface Receptors><Cell surface><Cells><Cellular Metabolic Process><CoV-2><CoV2><Collaborations><Complex><Computer software><Coronaviridae><Coronavirus><D-Glucose><Data><Development><Dextrose><ERVs><Endogenous Retroviruses><Epitheliasin Gene><Epitopes><Erythrocyte/Hepatoma Glucose Transporter><Family><FeLV><Feline Leukemia Virus><Feline Lymphoma Virus><France><G Protein-Complex Receptor><G Protein-Coupled Receptor Genes><G-Protein-Coupled Receptors><GLUT><GLUT1><GPCR><Gln><Glucose><Glucose Binding Protein><Glucose Transport Protein><Glucose Transporter><Glucose Transporter 1><Glutamine><Glycoproteins><Goals><HERVs><HTLV Viruses><HTLV group><Human><Human Endogenous Retroviruses><Human Genome><Human T-Cell Leukemia Viruses><Human T-Cell Leukemia-Lymphoma Viruses><Human T-lymphotropic Viruses><Immune response><Immunological response><Inflammation><L-Arginine><L-Glutamine><L-Serine><Ligands><MGC34555><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Methodology><Mice><Mice Mammals><Modern Man><Molecular><Molecular Interaction><Murine><Mus><Neutral Amino Acid Transport Proteins><Neutral Amino Acid Transport Systems><Neutral Amino Acid Transporters><Normal Cell><Nutrient><Oncogenesis><Oncogenic><PRSS10><Papio><Papios><Paris><Paris, France><Play><Process><Proteins><Q Levoglutamide><Q. Levoglutamide><Receptor Cell><Receptor Protein><Research><Retroviridae><Retroviruses><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><SCYA21><SLC><SLC2A1><SLC2A1 gene><Savanna Baboons><Serine><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Software><Solute Carrier Family 2, Facilitated Glucose Transporter, Member 1><Specificity><Structure><Supersecondary Protein Structure><Surface Proteins><System><TCA4><TMPRSS2><TMPRSS2 gene><Viral Diseases><Viral Receptor><Virus Diseases><Virus Receptors><Virus-Retrovirus><Wuhan coronavirus><Zwitterionic Amino Acid Transport Proteins><Zwitterionic Amino Acid Transport Systems><Zwitterionic Amino Acid Transporters><aminoacid><angiotensin converting enzyme 2><angiotensin converting enzyme II><anti-cancer><anti-viral agents><anti-viral compound><anti-viral drugs><anti-viral medication><anti-viral therapeutic><anti-virals><anticancer><antiviral compound><antiviral medication><antiviral therapeutic><beta CoV><beta coronavirus><betaCoV><betacoronavirus><bio-markers><biologic marker><biomarker><cell metabolism><cellular metabaolism><computational pipelines><corona virus><coronavirus disease 2019 virus><coronavirus disease-19 virus><data-driven model><design><designing><develop software><developing computer software><developmental><enverin><hCoV19><host response><human whole genome><immune system response><immunoresponse><improved><innovate><innovation><innovative><member><model building><nCoV2><receptor><receptor binding><receptor bound><social role><software development><syncytin><tool><tumorigenesis><viral infection><virus envelope><virus infection><virus-induced disease><β CoV><β coronavirus><βCoV>